Cost‑effectiveness Analysis of Helicobacter pylori Eradication Therapy in First-Degree Relatives of Patients with Gastric Cancer

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Maleki Kakelar H, Barzegari A, Dehghani J, et al. Pathogenicity of Helicobacter pylori in cancer development and impacts of vaccination. Gastric Cancer. 2019;22(1):23–36. doi:10.1007/s10120-018-0867-1
   PubMed Web of Science ®Google Scholar
• Plummer M, Franceschi S, Vignat J, Forman D, de Martel C. Global burden of gastric cancer attributable to Helicobacter pylori. Int J Cancer. 2015;136(2):487–490. doi:10.1002/ijc.28999
   PubMed Web of Science ®Google Scholar
• Feng R-M, Zong Y-N, Cao S-M, Xu R-H. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics? Cancer Communications. 2019;39(1):22. doi:10.1186/s40880-019-0368-6
   PubMed Web of Science ®Google Scholar
• Chen WQ, Zheng RS, Baade PD, et al. Cancer Statistics in China, 2015. CA: A Cancer Journal for Clinicians. 2016;66(2):115–132. doi:10.3322/caac.21338
   PubMed Web of Science ®Google Scholar
• Wang F-H, Shen L, Li J, et al. The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer. Cancer Communications. 2019;39(1):10. doi:10.1186/s40880-019-0349-9
   PubMed Web of Science ®Google Scholar
• Sugano K, Tack J, Kuipers EJ, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64(9):1353–1367. doi:10.1136/gutjnl-2015-309252
   PubMed Web of Science ®Google Scholar
• Liu WZ, Xie Y, Lu H, et al. Fifth Chinese National Consensus Report on the management of Helicobacter pylori infection. Helicobacter. 2018;23(2):e12475. doi:10.1111/hel.12475
   PubMed Web of Science ®Google Scholar
• Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG Clinical Guideline: treatment of Helicobacter pylori Infection. Am J Gastroenterol. 2017;112(2):212–239. doi:10.1038/ajg.2016.563
   PubMed Web of Science ®Google Scholar
• El-Serag HB, Kao JY, Kanwal F, et al. Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States. Clin Gastroenterol Hepatol. 2018;16(7):992–1002. doi:10.1016/j.cgh.2018.03.013
   PubMed Web of Science ®Google Scholar
• Choi YJ, Kim N. Gastric cancer and family history. Korean J Intern Med. 2016;31(6):1042–1053. doi:10.3904/kjim.2016.147
   PubMed Web of Science ®Google Scholar
• Choi IJ, Kim CG, Lee JY, et al. Family history of gastric cancer and Helicobacter pylori treatment. N Engl J Med. 2020;382(5):427–436. doi:10.1056/NEJMoa1909666
   PubMed Web of Science ®Google Scholar
• Briggs A, Sculpher M. An introduction to Markov modelling for economic evaluation. Pharmacoeconomics. 1998;13(4):397–409. doi:10.2165/00019053-199813040-00003
   PubMed Web of Science ®Google Scholar
• Xue Y, Zhou L-Y, Lu H-P, Liu J-Z. Recurrence of Helicobacter pylori infection: incidence and influential factors. Chin Med J. 2019;132(7):765–771. doi:10.1097/CM9.0000000000000146
   PubMed Web of Science ®Google Scholar
• Yang L, Zheng R, Wang N, et al. Incidence and mortality of stomach cancer in China, 2014. Chin J Cancer Res. 2018;30(3):291–298. doi:10.21147/j.issn.1000-9604.2018.03.01
   PubMed Web of Science ®Google Scholar
• Huang H-Y, Shi J-F, Guo L-W, et al. Expenditure and financial burden for common cancers in China: a hospital-based multicentre cross-sectional study. Lancet. 2016;388:10. doi:10.1016/S0140-6736(16)31937-7
   Web of Science ®Google Scholar
• Han Y, Yan T, Ma H, et al. Cost-effectiveness analysis of Helicobacter pylori eradication therapy for prevention of gastric cancer: a Markov model. Dig Dis Sci. 2019;65(6):1679–1688. doi:10.1007/s10620-019-05910-1
   Web of Science ®Google Scholar
• Fock KM. Review article: the epidemiology and prevention of gastric cancer. Aliment Pharmacol Ther. 2014;40(3):250–260. doi:10.1111/apt.12814
   PubMed Web of Science ®Google Scholar
• Thrift AP, El-Serag HB. Burden of gastric cancer. Clin Gastroenterol Hepatol. 2020;18(3):534–542. doi:10.1016/j.cgh.2019.07.045
   PubMed Web of Science ®Google Scholar
• Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014;23(5):700–713. doi:10.1158/1055-9965.EPI-13-1057
   PubMed Web of Science ®Google Scholar
• Amieva M, Peek RM. Pathobiology of Helicobacter pylori–induced gastric cancer. Gastroenterology. 2016;150(1):64–78. doi:10.1053/j.gastro.2015.09.004
   PubMed Web of Science ®Google Scholar
• Blanchard TG, Czinn SJ. Identification of Helicobacter pylori and the evolution of an efficacious childhood vaccine to protect against gastritis and peptic ulcer disease. Pediatr Res. 2017;81(1–2):170–176. doi:10.1038/pr.2016.199
   PubMed Web of Science ®Google Scholar
• Yusefi AR, Bagheri Lankarani K, Bastani P, Radinmanesh M, Kavosi Z. Risk factors for gastric cancer: a systematic review. Asian Pac J Cancer Prev. 2018;19(3):591–603. doi:10.22034/APJCP.2018.19.3.591
   PubMedGoogle Scholar
• Yu GQ, Hu N, Wang LM, et al. Gastric microbiota features associated with cancer risk factors and clinical outcomes: A pilot study in gastric cardia cancer patients from Shanxi, China. Int J Cancer. 2017;141(1):45–51. doi:10.1002/ijc.30700
   PubMed Web of Science ®Google Scholar
• Xie F, Luo N, Blackhouse G, Goeree R, Lee H-P. Cost-effectiveness analysis of Helicobacter pylori screening in prevention of gastric cancer in Chinese. Int J Technol Assess Health Care. 2008;24(1):87–95. doi:10.1017/S0266462307080117
   Web of Science ®Google Scholar
• Kowada A. Cost-effectiveness of Helicobacter pylori screening followed by eradication treatment for employees in Japan. Epidemiol Infect. 2018;146(14):1834–1840. doi:10.1017/S095026881800208X
   Web of Science ®Google Scholar
• Kowada A. Cost-effectiveness of Helicobacter pylori test and eradication versus upper gastrointestinal series versus endoscopy for gastric cancer mortality and outcomes in high prevalence countries. Scand J Gastroenterol. 2019;54(6):685–689. doi:10.1080/00365521.2019.1627408
   PubMed Web of Science ®Google Scholar
• Du Y, Zhu H, Liu J, et al. Consensus on eradication of Helicobacter pylori and prevention and control of gastric cancer in China (2019, Shanghai). J Gastroenterol Hepatol. 2020;35(4):624–629. doi:10.1111/jgh.14947
   Web of Science ®Google Scholar
• Hu Y, Zhu Y, Lu N-H. Primary antibiotic resistance of Helicobacter pylori in China. Dig Dis Sci. 2017;62(5):1146–1154. doi:10.1007/s10620-017-4536-8
   PubMed Web of Science ®Google Scholar
• Yaghoobi M, McNabb-Baltar J, Bijarchi R, Hunt RH. What is the quantitative risk of gastric cancer in the first-degree relatives of patients? A meta-analysis. World J Gastroenterology. 2017;23(13):2435–2442. doi:10.3748/wjg.v23.i13.2435
   Web of Science ®Google Scholar